Evidence map›Paper›PMID 35131171›Full record

ArticleAutonomic neuroscience : basic & clinical2022

A new lead: Sacubitril-valsartan's unique benefit in HFrEF could lie with sympathoinhibition.

Sangeetha Nathaniel, Shane McGinty, Melissa A Witman, David G Edwards, William B Farquhar, Vinay Hosmane, Megan M Wenner

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Autonomic neuroscience : basic & clinical, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sangeetha NathanielDepartment of Kinesiology and Applied Physiology, University of Delaware, Newark, DE, USA.
Shane McGintyDepartment of Kinesiology and Applied Physiology, University of Delaware, Newark, DE, USA.
Melissa A WitmanDepartment of Kinesiology and Applied Physiology, University of Delaware, Newark, DE, USA.
David G EdwardsDepartment of Kinesiology and Applied Physiology, University of Delaware, Newark, DE, USA.
William B FarquharDepartment of Kinesiology and Applied Physiology, University of Delaware, Newark, DE, USA.
Vinay HosmaneHosmane Cardiology and Section of Cardiology, Christiana Care Healthcare System, Newark, DE, USA.
Megan M WennerDepartment of Kinesiology and Applied Physiology, University of Delaware, Newark, DE, USA. Electronic address: mwenner@udel.edu.

Funding

Vascular Consequences of Duchenne Muscular DystrophyP20GM113125 · NIGMS · UNIVERSITY OF DELAWARE · PI LENNON, SHANNON L. · 2016 to 2025
$23.3M
NIGMS NIH HHS P20 GM113125
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heart FailureAminobutyratesBiphenyl CompoundsHumansPilot ProjectsStroke VolumeValsartanAminobutyratesBiphenyl CompoundssacubitrilValsartan

Identifiers

PMID35131171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.